AU/NZ

Cellulite Reduction

What is EMTONE?

EMTONE simultaneously combines thermal and mechanical energy to treat major factors that contribute to cellulite.

It enables treatment of the root causes instead of suppressing the symptoms.

Key benefits

ALL CAUSES OF CELLULITE & LOOSE SKIN

All major contributing factors to cellulite and loose skin can be treated non invasively

7ALL SKIN & BODY TYPES

No BMI or skin type restrictions

SHORTER TREATMENT & BETTER RESULTS

Synergistic emission leads to halving the treatment time while enhancing the impact on connective tissue

Seeing is believing

Click on the desired body area to view EMTONE results.
BEFORE
AFTER
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 3rd TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 3rd TREATMENT
AFTER 3rd TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 3rd TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT
AFTER 4ᵀᴴ TREATMENT

Patient results and experience may vary.

How does EMTONE work?

EMTONE simultaneously emits both radiofrequency and TPE (Targeted pressure energy).

When these technologies are combined into one treatment, there is a synergistic effect that neither technology can achieve on its own.(1)

It results in diminishing of fat chambers, remodelling of collagen fibers, restoring skin elasticity, increase in blood flow and metabolic waste removal.

Why say YES to EMTONE?

Clinical studies suggest that simultaneous emission leads to significantly higher impact on
connective tissue than consecutive application of both energies.(1)

59%

Higher increase in collagen(1)

64%

Higher increase in elastin(1)

44%

Higher increase in thickness of dermis(1)

We recommend following healthy energy-controlled diet and physical activity.
This product is not available for purchase by the general public.
Patient results and experience may vary.
The findings showed consistent outcomes across the clinical studies.

Become a BTL Partner today.

Elevate your practice offering with award-winning devices.

BTL partners with clinics committed to clinical excellence and innovation.

Evidence based technologies with global clinical adoption

Comprehensive training and marketing support

Dedicated technical service and ongoing partnership

Devices registered and compliant in Australia and New Zealand

Fill in your details and our team will be in touch to discuss your goals and product suitability.

Request BTL Product Information

Country(Required)
Interested in(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

By filling the form I am aware that BTL contacts me to keep me informed about news of BTL Group and about its products and services.

Contact BTL Australia

Address:
Administration & Service:
Unit 5 / 10 Enterprise Close
West Gosford NSW 2250

Showroom:
Suite 2.05, Level 2, Building D, Talavera Corporate Center,
12-24 RTalavera Road, Macquarie Park NSW 2113

Email: info@btlmed.com.au
Phone: 0422 608 123

Contact BTL New Zealand

Address:
130 St Georges Bay Rd, Parnell,
Auckland 1052

Email: ehab@btlmed.nz / info@btlmed.nz
Ehab Jirgis , Business Development Manager +64 21 284 2628

Clinical studies by sponsor BTL Industries JSC
(1) Kinney BM, Kanakov D, Yonkova P. Histological examination of skin tissue in the porcine animal model after simultaneous and consecutive application of monopolar radiofrequency and targeted pressure energy. J Cosmet Dermatol. 2020;19(1):93-101.
(2) Fritz K, Salavastru C, Gyurova M. Clinical evaluation of simultaneously applied monopolar radiofrequency and targeted pressure energy as a new method for noninvasive treatment of cellulite in postpubertal women. J Cosmet Dermatol. 2018;17(3):361-364.
(3) Fritz K, Salavastru C, Gyurova M. Reduction of abdominal skin laxity in women postvaginal delivery using the synergistic emission of radiofrequency and targeted pressure energies. J Cosmet Dermatol. 2018;17(5):766-769.